The StarMap® Framework
Scaling beyond pilots is where MedTech ventures die.
StarMap is EvoMed Consulting's physician-built framework for clinical adoption: the clinical-strategic navigation system for the stage where assumptions get expensive and mistakes compound.
Who the StarMap is for
Three seats at the same table.
One shared blind spot.
Founders, accelerators, and investors all lose money to the same thing: structural misalignment that no pitch deck reveals.
-
MedTech Innovators
Validate product-market fit before burning cash. StarMap replaces costly trial-and-error with clarity on where clinical reality meets commercial logic. €50-100kof trial-and-error a diagnosis saves -
Accelerators
Estimates from Carta, Dealroom and CB Insights put 30 to 40% of VC-backed startups in zombie territory. StarMap sharpens cohort quality by surfacing misalignment before it becomes portfolio drag. 30 to 40%of VC-backed startups are zombies -
Investors & VCs
Three out of four venture-backed MedTech startups never return the investment. StarMap reduces hidden structural risk before deployment. 75%never return the investment
Most MedTech teams are technically strong. Many are well funded. Some are even certified and compliant. And still,
fail to reach sustainable scale.
Venture-backed MedTech startups that never generate a return. Sources: Nelson (2025), MD+DI; TTi Health Research.
The Constellation Effect
Single stars don't guide anyone.
Constellations do.
Individual success factors bleed impact when viewed in isolation. Strategic resilience comes from system-wide alignment: seven success factors, connected through workflow alignment.
Success factor 1 of 7
Specialization & Clinical Depth
Success doesn't come from building a product for everyone. It comes from solving a defined, urgent problem for a clearly targeted patient group. Specialization builds clinical credibility and relevance.
"If you try to be everything to everyone, you risk being no one's first choice."
Success factor 2 of 7
Predictability of Services
Technologies that disrupt clinical workflows without clear advantages get resisted. Scalable solutions improve efficiency, reduce variability, and slot into real-world hospital routines with minimal training or disruption.
Success factor 3 of 7
Ambulantization & Digitalization
Care is shifting beyond hospitals into outpatient clinics and patients' homes, and MedTech needs to keep pace. Tools that only work in traditional hospital settings risk obsolescence. Over 75% of MedTech leaders say they are rethinking their strategies to accommodate this shift.
Source: Accenture and AdvaMed survey of MedTech executives (2022), reported by MedTech Dive.
Success factor 4 of 7
Cooperation & Ecosystem Fit
Interoperability and collaboration are non-negotiable. Tools that don't integrate with existing systems like EHRs (electronic health records), or fail to support cross-provider coordination, end up siloed and unused.
"Future success will depend on targeting the entire care pathway, not just standalone products."86% of MedTech executives, Accenture and AdvaMed survey (2022)
Success factor 5 of 7
Economic Viability
Even a clinically brilliant tool stalls if hospitals can't justify the cost. ROI, reimbursement pathways, and a compelling business case are essential. Clinical benefit alone doesn't carry a venture; financial sustainability for every stakeholder does.
Success factor 6 of 7
Quality of Care
Evidence of improved outcomes is fast becoming the gold standard. Fewer readmissions, faster recovery, higher patient satisfaction: measurable impact now drives both adoption and funding.
Success factor 7 of 7
Implementation Friction
The best product means nothing if it never gets used. Lengthy onboarding, staff resistance, IT hurdles, and regulatory delays derail even the most promising solutions. Minimizing friction is critical to scaling adoption.
The Methodology Guide
From constellation to roadmap.
The StarMap Methodology Guide translates this system-wide logic into an actionable roadmap for your venture. Not a checklist. A navigation system. The full framework, with the founder archetypes and the Constellation Effect, is in the book Fit before Scale.
How you work with StarMap
Three steps. Each one earns the next.
Every engagement starts with a diagnosis and only deepens where it says it should. No retainer before the fit is proven.
-
Step 1
Discovery
The diagnosis before any prescription. A structured self-assessment, a 120-minute CrossCheck session with EvoMed's experts, practicing physicians, and a board-ready Mission Brief that names the emergency brake in your clinical-commercial alignment and prescribes the Navigator modules you actually need.
Discuss Discovery in a Screening CallFixed fee€1,800non-funded, early-stage startupsFixed fee€3,500revenue-stage companies -
Step 2
Navigator
Modular by design. Your Discovery Mission Brief dictates which of the five modules get activated: Clinical Problem Decision Lab, Workflow Alignment Session, Healthcare Stakeholder Powermap, Adoption Sprint and Product Friction Audit. We design the engine, your team builds it with our templates, and every deliverable stays yours.
Baseline€18,000For teams that build it themselvesStandard€27,000What most Innovators chooseGold Standard€36,000For ambitious ventures that want to become the standard of care -
Step 3
Explorer
A continuous strategic partner with executive-level clinical judgment on call, for ventures and portfolios that keep making high-stakes decisions. Bi-weekly bridge audits, a stop/go filter for everything that goes to a hospital, and a monthly one-page report for your board.
AccessInvite onlyafter Navigator, minimum engagement of 6 months
Running a program or a fund? The offer looks different for you.
Companies, clinics and programs we have worked with
The engine
StarMap runs on StarMap OS.
StarMap OS is the AI-native assessment engine that applies the framework at scale: one venture or an entire accelerator cohort, scored across the seven success factors, every score cross-checked by a physician. It is already screening the Life Science Bootcamp cohort at Futury. You don't pay for the tool; you pay for the clinical interpretation behind it.
The most expensive mistake in MedTech, in four minutes.
Dr. Havkic on the mistake that costs MedTech founders the most, and how StarMap catches it early.
MedTech World"It's great to see the StarMap gaining recognition. Bridging that gap between innovation and real-world impact is exactly what the MedTech field needs."
Success stories
Documented, not claimed.
Read the full case reports"EvoMed Consulting didn't just advise us on individual questions, they guide us through complexity. Dr. Havkic helped us understand where clinical reality, regulation, and reimbursement truly intersect, and how to make the right decisions at each step. That guidance gave us clarity, confidence, and a much smoother path to adoption."
"I was impressed with the medical expertise of the EvoMed team and their ability to integrate it seamlessly into our business operations. Their consulting was invaluable in navigating the complex medical imaging diagnostics industry, making our products even more user-friendly and patient-safe."
"The most eye-opening insight was realizing how crucial technical integration will be, and which metrics I need to track as soon as I start working with clinics. I now have a clear view of the immediate, mid-term, and long-term steps."
"I appreciate working with Dr. Havkic. He consistently manages to bring together medical and business perspectives, and this holds true even with innovative tech topics like analytics."
Bedside to boardroom
Dr. med. univ. Amel Havkic, MBA. Physician, founder of EvoMed Consulting and creator of StarMap. Best Rising Star of the Industry 2026, MedTech World Dubai."As an ICU lead and strategic advisor, I have spent my career stabilizing both critical patients and stalling MedTech ventures. The StarMap is not a theoretical framework. It is the codified methodology I use to isolate the structural risks that cause 75% of innovations to fail."
Questions we get asked
StarMap, in plain terms.
What is StarMap?
StarMap is EvoMed Consulting's proprietary framework for de-risking MedTech scaling and clinical adoption. It assesses a venture across seven success factors, called constellation points, to show where a product will stall after regulatory approval and what to fix first. It was developed by Dr. Amel Havkic, a practicing physician and MedTech advisor.
What are the seven StarMap success factors?
Specialization and clinical depth, predictability of services, ambulantization and digitalization, cooperation and ecosystem fit, economic viability, quality of care, and implementation friction. StarMap scores how well a venture is aligned on each and how the factors interact.
Who is StarMap for?
MedTech founders who want to validate clinical adoption before burning capital, accelerators screening applicants and cohorts, and investors adding a clinical due-diligence lens to their assessment. The diagnosis is the same for all three.
What is the StarMap Alignment Check?
A free, 14-question self-assessment that takes under three minutes and shows how a MedTech solution maps against the seven success factors. It is the entry point before a Discovery engagement.
What is the difference between StarMap and StarMap OS?
StarMap is the framework and methodology. StarMap OS is the AI-native assessment engine that runs it at scale, scoring single ventures or whole accelerator cohorts, with every score cross-checked by a physician.
Is StarMap a replacement for regulatory or reimbursement consulting?
No. StarMap sits before and around those steps. It shows whether the venture will be adopted in real clinical routine once approval and reimbursement are in place, which is where most MedTech failures actually happen.
Find out where your stars are aligned.
A short screening call clarifies whether StarMap fits your situation and what the right next step is. Prefer to start on your own? The free Alignment Check takes under three minutes.